These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10930447)

  • 1. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.
    Gao Y; Lecker S; Post MJ; Hietaranta AJ; Li J; Volk R; Li M; Sato K; Saluja AK; Steer ML; Goldberg AL; Simons M
    J Clin Invest; 2000 Aug; 106(3):439-48. PubMed ID: 10930447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PR39, a peptide regulator of angiogenesis.
    Li J; Post M; Volk R; Gao Y; Li M; Metais C; Sato K; Tsai J; Aird W; Rosenberg RD; Hampton TG; Sellke F; Carmeliet P; Simons M
    Nat Med; 2000 Jan; 6(1):49-55. PubMed ID: 10613823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
    Chen Z; Hagler J; Palombella VJ; Melandri F; Scherer D; Ballard D; Maniatis T
    Genes Dev; 1995 Jul; 9(13):1586-97. PubMed ID: 7628694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity.
    Gaczynska M; Osmulski PA; Gao Y; Post MJ; Simons M
    Biochemistry; 2003 Jul; 42(29):8663-70. PubMed ID: 12873125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel in vitro assay for deubiquitination of I kappa B alpha.
    Strayhorn WD; Wadzinski BE
    Arch Biochem Biophys; 2002 Apr; 400(1):76-84. PubMed ID: 11913973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product.
    Li CC; Dai RM; Longo DL
    Biochem Biophys Res Commun; 1995 Oct; 215(1):292-301. PubMed ID: 7575604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Palombella VJ; Rando OJ; Goldberg AL; Maniatis T
    Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase.
    Yaron A; Gonen H; Alkalay I; Hatzubai A; Jung S; Beyth S; Mercurio F; Manning AM; Ciechanover A; Ben-Neriah Y
    EMBO J; 1997 Nov; 16(21):6486-94. PubMed ID: 9351830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated I kappa B alpha degradation.
    Bao J; Sato K; Li M; Gao Y; Abid R; Aird W; Simons M; Post MJ
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2612-8. PubMed ID: 11709430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between HTLV-1 Tax and I kappa B alpha is dependent on the I kappa B alpha phosphorylation state.
    Petropoulos L; Hiscott J
    Virology; 1998 Dec; 252(1):189-99. PubMed ID: 9875328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome regulation of Fas ligand cytotoxicity.
    Matsui K; Omura S; Cui H; Schauer SL; Sonenshein GE; Ju ST
    Eur J Immunol; 1997 Sep; 27(9):2269-78. PubMed ID: 9341769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor.
    Maggirwar SB; Harhaj E; Sun SC
    Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells.
    Traenckner EB; Baeuerle PA
    J Cell Sci Suppl; 1995; 19():79-84. PubMed ID: 8655651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
    Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
    J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
    Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y
    J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
    Krappmann D; Wulczyn FG; Scheidereit C
    EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.
    Van Antwerp DJ; Verma IM
    Mol Cell Biol; 1996 Nov; 16(11):6037-45. PubMed ID: 8887633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappa B regulates the LPS-induced expression of interleukin 12 p40 in murine peritoneal macrophages: roles of PKC, PKA, ERK, p38 MAPK, and proteasome.
    Zhang JS; Feng WG; Li CL; Wang XY; Chang ZL
    Cell Immunol; 2000 Aug; 204(1):38-45. PubMed ID: 11006016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.
    Kroll M; Conconi M; Desterro MJ; Marin A; Thomas D; Friguet B; Hay RT; Virelizier JL; Arenzana-Seisdedos F; Rodriguez MS
    Oncogene; 1997 Oct; 15(15):1841-50. PubMed ID: 9362451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.